upadacitinib
abbvie
[' upa ']
data from upa trials showing no large differences with biologic exposure vs bio naive. endoscopy response rates are good. if biologic exposed, may need 30mg in maintenance therapy as 15mg had slightly decreased rates of response and remission #ecco2023 
Associate Professor, Gastroenterologist - IBD, microbiome, Co-founder https://t.co/Xhgfwnb0dG (digital tool -  management of IBD and bowel preparation)